{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:12:33Z","timestamp":1767834753652,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.beha.2023.101525","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T19:33:06Z","timestamp":1700940786000},"page":"101525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Best practice &amp; research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors"],"prefix":"10.1016","volume":"36","author":[{"given":"Stephanie M.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2023.101525_bib1","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","article-title":"High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group","volume":"21","author":"Bhatia","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2008.04.067","article-title":"Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose","volume":"72","author":"Constine","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beha.2023.101525_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.beha.2023.101525_bib4","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ijc.22261","article-title":"Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: a population-based study","volume":"120","author":"Taylor","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib6","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","article-title":"Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2023.101525_bib7","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.beha.2023.101525_bib8","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1200\/JCO.2004.11.032","article-title":"Development of risk-based guidelines for pediatric cancer survivors: the children's oncology group long-term follow-up guidelines from the children's oncology group late effects committee and nursing discipline","volume":"22","author":"Landier","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib9","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1200\/JCO.2012.46.5732","article-title":"Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma","volume":"31","author":"Ng","year":"2013","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib10","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.20.00562","article-title":"Updated breast cancer surveillance recommendations for female survivors of childhood, adolescent, and young adult cancer from the international guideline harmonization group","volume":"38","author":"Mulder","year":"2020","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clbc.2013.06.001","article-title":"Prophylactic mastectomy: a treatment alternative for Hodgkin survivors?","volume":"13","author":"Boucher","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib12","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1200\/JCO.18.02219","article-title":"Mortality after breast cancer among survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"37","author":"Moskowitz","year":"2019","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib13","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1245\/s10434-016-5443-5","article-title":"Contralateral prophylactic mastectomy (CPM) consensus statement from the American society of breast surgeons: data on CPM outcomes and risks","volume":"23","author":"Boughey","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib14","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1245\/s10434-022-11947-w","article-title":"Surgical management and contralateral breast cancer risk in women with history of radiation therapy for Hodgkin lymphoma: results from a population-based cohort","volume":"29","author":"Eisenberg","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2000.18.3.498","article-title":"Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment","volume":"18","author":"Swerdlow","year":"2000","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2","article-title":"High risk of breast carcinoma after irradiation of young women with Hodgkin's disease","volume":"79","author":"Aisenberg","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib17","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes","volume":"27","author":"De Bruin","year":"2009","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib18","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1200\/JCO.2008.20.7738","article-title":"Radiation dose and breast cancer risk in the childhood cancer survivor study","volume":"27","author":"Inskip","year":"2009","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2017.06.028","article-title":"Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: a French multicentre cohort study","volume":"124","author":"Demoor-Goldschmidt","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib20","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/cncr.23081","article-title":"Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma","volume":"110","author":"Hodgson","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103326","article-title":"The impact of modern radiotherapy on radiation-induced late sequelae: focus on early-stage mediastinal classical Hodgkin Lymphoma. A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","volume":"161","author":"Iorio","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.beha.2023.101525_bib22","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 Years after treatment for hodgkin's lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2023.101525_bib23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/bjc.2017.169","article-title":"Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Moskowitz","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease","volume":"95","author":"van Leeuwen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2023.101525_bib25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijrobp.2017.07.016","article-title":"Breast cancer risk after radiation therapy for Hodgkin lymphoma: influence of gonadal hormone exposure","volume":"99","author":"Krul","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beha.2023.101525_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/cncr.34065","article-title":"Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: results from a population-based cohort","volume":"128","author":"Wong","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiol.14131789","article-title":"Radiologic features of breast cancer after mantle radiation therapy for Hodgkin disease: a study of 230 cases","volume":"272","author":"Allen","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.beha.2023.101525_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnci\/85.1.25","article-title":"Breast cancer after treatment of Hodgkin's disease","volume":"85","author":"Hancock","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2023.101525_bib29","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170824","article-title":"Clinical and histological features of second breast cancers following radiotherapy for childhood and young adult malignancy","volume":"91","author":"Demoor-Goldschmidt","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.beha.2023.101525_bib30","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.2010.32.4079","article-title":"Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study","volume":"29","author":"Elkin","year":"2011","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"issue":"444\u201355","key":"10.1016\/j.beha.2023.101525_bib31","first-page":"W144","article-title":"Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer","volume":"152","author":"Henderson","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2023.101525_bib32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.bjc.6605877","article-title":"Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy","volume":"103","author":"Dores","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1634\/theoncologist.2011-0451","article-title":"Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma","volume":"17","author":"Veit-Rubin","year":"2012","journal-title":"Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib34","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2010.29.5683","article-title":"Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study","volume":"28","author":"Milano","year":"2010","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/jamaoncol.2017.4887","article-title":"Association of treatment for Hodgkin lymphoma with estrogen receptor status of subsequent breast cancers","volume":"4","author":"Withrow","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/annonc\/mdu017","article-title":"Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma","volume":"25","author":"Horst","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/1078-0432.CCR-06-1490","article-title":"Radiation effects on development of HER2-positive breast carcinomas","volume":"13","author":"Castiglioni","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2023.101525_bib38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1200\/JCO.2000.18.4.765","article-title":"Management of breast cancer after Hodgkin's disease","volume":"18","author":"Wolden","year":"2000","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.critrevonc.2011.01.005","article-title":"Breast cancer occurred after Hodgkin's disease: clinico-pathological features, treatments and outcome: analysis of 214 cases","volume":"81","author":"Cutuli","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.beha.2023.101525_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacr.2009.09.022","article-title":"Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer","volume":"7","author":"Lee","year":"2010","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.beha.2023.101525_bib41","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","article-title":"Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group","volume":"46","author":"Sardanelli","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib42","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.beha.2023.101525_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjc.6602974","article-title":"High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening","volume":"94","author":"Greenfield","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1524-4741.2007.00524.x","article-title":"Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease","volume":"14","author":"Kwong","year":"2008","journal-title":"Breast J"},{"key":"10.1016\/j.beha.2023.101525_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/annonc\/mdm440","article-title":"Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma","volume":"19","author":"Lee","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.10100991","article-title":"Screening breast MR imaging in women with a history of chest irradiation","volume":"259","author":"Sung","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.beha.2023.101525_bib47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cncr.27771","article-title":"Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy","volume":"119","author":"Freitas","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib48","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cncr.28747","article-title":"Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging","volume":"120","author":"Tieu","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib49","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.bjc.6605215","article-title":"The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage","volume":"101","author":"Howell","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib50","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1200\/JCO.1992.10.11.1674","article-title":"Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients","volume":"10","author":"Yahalom","year":"1992","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1748-717X-4-19","article-title":"Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis","volume":"4","author":"Alm El-Din","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/SAP.0000000000002087","article-title":"Outcomes following breast reconstruction in patients with prior mantle radiation for treatment of hodgkin's lymphoma","volume":"84","author":"Freniere","year":"2020","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.beha.2023.101525_bib53","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.ijrobp.2011.03.013","article-title":"Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option","volume":"82","author":"Haberer","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 3","key":"10.1016\/j.beha.2023.101525_bib54","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0960-9776(11)70304-6","article-title":"Local therapy for breast cancer in malignant lymphoma survivors","volume":"20","author":"Intra","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.beha.2023.101525_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00000421-200102000-00005","article-title":"Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma","volume":"24","author":"Deutsch","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101525_bib56","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-conserving surgery with or without irradiation in early breast cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2023.101525_bib58","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2017.03.016","article-title":"NRG oncology-radiation therapy oncology group study 1014: 1-year toxicity report from a phase 2 study of repeat breast-preserving surgery and 3-dimensional conformal partial-breast reirradiation for in-breast recurrence","volume":"98","author":"Arthur","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beha.2023.101525_bib59","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ijrobp.2007.06.060","article-title":"Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?","volume":"69","author":"Beckham","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beha.2023.101525_bib60","first-page":"1063","article-title":"Breast cancer following radiation for Hodgkin lymphoma: clinical scenarios and risk-reducing strategies","volume":"30","author":"Overholser","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.beha.2023.101525_bib61","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ijrobp.2009.10.006","article-title":"Clinical results of image-guided deep inspiration breath hold breast irradiation","volume":"78","author":"Borst","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beha.2023.101525_bib62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ijrobp.2015.09.018","article-title":"Initial report of a prospective dosimetric and clinical feasibility trial demonstrates the potential of protons to increase the therapeutic ratio in breast cancer compared with photons","volume":"95","author":"Bradley","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beha.2023.101525_bib63","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2023.101525_bib64","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-20-3609","article-title":"A randomized phase IIb study of low-dose tamoxifen in chest-irradiated cancer survivors at risk for breast cancer","volume":"27","author":"Bhatia","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2023.101525_bib65","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/cncr.33596","article-title":"Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors","volume":"127","author":"Sella","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2023.101525_bib66","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1200\/JCO.18.01779","article-title":"Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia","volume":"37","author":"DeCensi","year":"2019","journal-title":"J Clin Oncol : Offi. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.beha.2023.101525_bib67","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1002\/cncr.32192","article-title":"Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer","volume":"125","author":"Wassermann","year":"2019","journal-title":"Cancer"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:09:07Z","timestamp":1761498547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692623000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521692623000865"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2023.101525","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2023.101525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101525"}}